文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

急性低氧性呼吸衰竭患者的数字孪生提示无创通气成败的机制基础

Digital Twins of Acute Hypoxemic Respiratory Failure Patients Suggest a Mechanistic Basis for Success and Failure of Noninvasive Ventilation.
PubMed 文献 · Crit Care Med · 2024-05-29
一句话结论数字孪生研究提示,无创通气成功的关键在于可施加较高吸气压力支持而不致潮气量过大,从而改善肺力学并降低肺损伤指数。

该研究基于30例中重度急性低氧性呼吸衰竭(AHRF)患者(高流量鼻导管治疗失败后接受无创通气(NIV)试验)的个体数据构建数字孪生,量化外源支持与患者呼吸做功对肺损伤指数的贡献。NIV成功组数字孪生2小时后总肺应力变化为-10.9 cm H2O、机械功率-13.4 J/min、总肺应变0.02;失败组分别为-0.35 cm H2O、-1.0 J/min、0.16。失败组vs成功组内源性PEEP 3.5 vs 2.3 cm H2O、吸气压力支持8.3 vs 22.3 cm H2O、潮气量10.9 vs 9.4 mL/kg。NIV成功者呼吸系统顺应性增加+25.0 mL/cm H2O,吸气肌肉压力降低-9.7 cm H2O,患者自主呼吸对总驱动压的贡献减少57.0%。结论提示NIV失败与仅能施加低水平吸气压力支持(以避免过大潮气量导致患者自致性肺损伤)相关。

要点

  • 数字孪生中,NIV成功组2小时后总肺应力变化-10.9 cm H2O、机械功率-13.4 J/min、总肺应变0.02,失败组分别为-0.35 cm H2O、-1.0 J/min、0.16。
  • NIV失败组vs成功组:内源性PEEP 3.5 vs 2.3 cm H2O,吸气压力支持8.3 vs 22.3 cm H2O,潮气量10.9 vs 9.4 mL/kg。
  • 数字孪生中,NIV成功使呼吸系统顺应性增加+25.0 mL/cm H2O,吸气肌肉压力降低-9.7 cm H2O,患者自主呼吸对总驱动压的贡献减少57.0%。
  • HFNC产生的PEEP与NIV设置相似,提示两者PEEP效应相近。
  • NIV失败见于仅能施加低水平吸气压力支持、否则潮气量过大有患者自致性肺损伤风险的患者。

适用人群与场景

  • 30例中重度急性低氧性呼吸衰竭患者,高流量鼻导管治疗失败后接受无创通气试验。

研究设计与关键结果

  • 研究类型:基于机制计算模型构建的数字孪生研究,使用30例中重度AHRF患者个体数据,患者HFNC失败后接受NIV试验。
  • NIV成功组数字孪生2小时后总肺应力变化均值(标准差)-10.9(6.2)cm H2O,失败组-0.35(3.38)cm H2O。
  • NIV成功组数字孪生2小时后机械功率变化-13.4(12.2)J/min,失败组-1.0(5.4)J/min。
  • NIV成功组数字孪生2小时后总肺应变变化0.02(0.24),失败组0.16(0.30)。
  • 数字孪生中HFNC产生的PEEP与NIV设置相似。
  • NIV失败组vs成功组:内源性PEEP 3.5(0.6)vs 2.3(0.8)cm H2O,吸气压力支持8.3(5.9)vs 22.3(7.2)cm H2O,潮气量10.9(1.2)vs 9.4(1.8)mL/kg。
  • 数字孪生中NIV成功使呼吸系统顺应性增加+25.0(16.4)mL/cm H2O,吸气肌肉压力降低-9.7(9.6)cm H2O,患者自主呼吸对总驱动压贡献减少57.0%。

证据类型、等级与局限

  • 证据类型:基于机制计算模型的数字孪生研究(非临床试验)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 数字孪生提示NIV成功与可施加较高吸气压力支持(而不致潮气量过大)相关,失败见于仅能施加低水平吸气压力支持以避免患者自致性肺损伤的患者。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To clarify the mechanistic basis for the success or failure of noninvasive ventilation (NIV) in acute hypoxemic respiratory failure (AHRF).

DESIGN: We created digital twins based on mechanistic computational models of individual patients with AHRF.

SETTING: Interdisciplinary Collaboration in Systems Medicine Research Network.

SUBJECTS: We used individual patient data from 30 moderate-to-severe AHRF patients who had failed high-flow nasal cannula (HFNC) therapy and subsequently underwent a trial of NIV.

INTERVENTIONS: Using the digital twins, we evaluated lung mechanics, quantified the separate contributions of external support and patient respiratory effort to lung injury indices, and investigated their relative impact on NIV success or failure.

MEASUREMENTS AND MAIN RESULTS: In digital twins of patients who successfully completed/failed NIV, after 2 hours of the trial the mean (sd) of the change in total lung stress was -10.9 (6.2)/-0.35 (3.38) cm H2O, mechanical power -13.4 (12.2)/-1.0 (5.4) J/min, and total lung strain 0.02 (0.24)/0.16 (0.30). In the digital twins, positive end-expiratory pressure (PEEP) produced by HFNC was similar to that set during NIV. In digital twins of patients who failed NIV vs. those who succeeded, intrinsic PEEP was 3.5 (0.6) vs. 2.3 (0.8) cm H2O, inspiratory pressure support was 8.3 (5.9) vs. 22.3 (7.2) cm H2O, and tidal volume was 10.9 (1.2) vs. 9.4 (1.8) mL/kg. In digital twins, successful NIV increased respiratory system compliance +25.0 (16.4) mL/cm H2O, lowered inspiratory muscle pressure -9.7 (9.6) cm H2O, and reduced the contribution of patient spontaneous breathing to total driving pressure by 57.0%.

CONCLUSIONS: In digital twins of AHRF patients, successful NIV improved lung mechanics, lowering respiratory effort and indices associated with lung injury. NIV failed in patients for whom only low levels of positive inspiratory pressure support could be applied without risking patient self-inflicted lung injury due to excessive tidal volumes.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Weaver L, Shamohammadi H, Saffaran S, et al. Digital Twins of Acute Hypoxemic Respiratory Failure Patients Suggest a Mechanistic Basis for Success and Failure of Noninvasive Ventilation. Crit Care Med. 2024. PMID: 39145711. doi:10.1097/CCM.0000000000006337

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。